Literature DB >> 17600291

Hunting for a pleural fluid test for mesothelioma: is soluble mesothelin the answer?

Y C Gary Lee.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17600291      PMCID： PMC2117246          DOI： 10.1136/thx.2006.076612

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  18 in total

1.  Operating characteristics of prostate-specific antigen in men with an initial PSA level of 3.0 ng/ml or lower.

Authors:  Ian M Thompson; Donna Pauler Ankerst; Chen Chi; M Scott Lucia; Phyllis J Goodman; John J Crowley; Howard L Parnes; Charles A Coltman
Journal:  JAMA       Date:  2005-07-06       Impact factor: 56.272

Review 2.  Transcriptional profiling of mesothelioma using microarrays.

Authors:  Gavin J Gordon
Journal:  Lung Cancer       Date:  2005-04-07       Impact factor: 5.705

3.  Prospective study of serum CA-125 levels as markers of ovarian cancer.

Authors:  K J Helzlsouer; T L Bush; A J Alberg; K M Bass; H Zacur; G W Comstock
Journal:  JAMA       Date:  1993-03-03       Impact factor: 56.272

4.  Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer.

Authors:  Raffit Hassan; Alan T Remaley; Maureen L Sampson; Jingli Zhang; Derrick D Cox; James Pingpank; Richard Alexander; Mark Willingham; Ira Pastan; Masanori Onda
Journal:  Clin Cancer Res       Date:  2006-01-15       Impact factor: 12.531

5.  Soluble mesothelin-related peptides in the diagnosis of malignant pleural mesothelioma.

Authors:  Arnaud Scherpereel; Bogdan Grigoriu; Massimo Conti; Thomas Gey; Marc Grégoire; Marie-Christine Copin; Patrick Devos; Bachar Chahine; Henri Porte; Philippe Lassalle
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

6.  Comparison of serum CA 19-9 and CEA levels in a population at high risk for colorectal cancer.

Authors:  E M Goldberg; L M Simunovic; S L Drake; W F Mueller; H L Verrill
Journal:  Hybridoma       Date:  1989-10

7.  Value of mesothelin immunostaining in the diagnosis of mesothelioma.

Authors:  Nelson G Ordóñez
Journal:  Mod Pathol       Date:  2003-03       Impact factor: 7.842

8.  L1CAM, INP10, P-cadherin, tPA and ITGB4 over-expression in malignant pleural mesotheliomas revealed by combined use of cDNA and tissue microarray.

Authors:  E Kettunen; A G Nicholson; B Nagy; H Wikman; J K Seppänen; T Stjernvall; T Ollikainen; V Kinnula; S Nordling; J Hollmén; S Anttila; S Knuutila
Journal:  Carcinogenesis       Date:  2004-09-24       Impact factor: 4.944

9.  Mesothelin-family proteins and diagnosis of mesothelioma.

Authors:  Bruce W S Robinson; Jenette Creaney; Richard Lake; Anna Nowak; A William Musk; Nick de Klerk; Pernilla Winzell; Karl Erik Hellstrom; Ingegerd Hellstrom
Journal:  Lancet       Date:  2003-11-15       Impact factor: 79.321

Review 10.  Mesothelin: a new target for immunotherapy.

Authors:  Raffit Hassan; Tapan Bera; Ira Pastan
Journal:  Clin Cancer Res       Date:  2004-06-15       Impact factor: 12.531
View more
  4 in total

Review 1.  Making cold malignant pleural effusions hot: driving novel immunotherapies.

Authors:  Pranav Murthy; Chigozirim N Ekeke; Kira L Russell; Samuel C Butler; Yue Wang; James D Luketich; Adam C Soloff; Rajeev Dhupar; Michael T Lotze
Journal:  Oncoimmunology       Date:  2019-01-22       Impact factor: 8.110

2.  fTwo novel biomarkers, mesothelin and HE4, for diagnosis of ovarian carcinoma.

Authors:  Ingegerd Hellstrom; Karl Erik Hellstrom
Journal:  Expert Opin Med Diagn       Date:  2011-05-01

Review 3.  Practical approaches to diagnose and treat for T0 malignant pleural mesothelioma: a proposal for diagnostic total parietal pleurectomy.

Authors:  Seiki Hasegawa; Nobuyuki Kondo; Seiji Matsumoto; Teruhisa Takuwa; Masaki Hashimoto; Hayato Orui; Shunichi Fukuda; Kazue Yoneda; Yoshitomo Okumura; Noriaki Tsubota; Kazuya Fukuoka; Ikuko Torii; Tohru Tsujimura; Takashi Nakano
Journal:  Int J Clin Oncol       Date:  2012-01-12       Impact factor: 3.402

Review 4.  CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives.

Authors:  Lourdes Cortes-Dericks; Ralph Alexander Schmid
Journal:  Respir Res       Date:  2017-04-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.